Joel Cousson Selected Research

Joel Cousson Research Topics

4	Critical Illness (Critically Ill) 01/2023 - 10/2016
2	Sepsis (Septicemia) 01/2017 - 10/2016
2	Infections 04/2013 - 11/2010
2	Coinfection 01/2012 - 11/2010
1	Obesity 01/2023
1	Septic Shock (Toxic Shock Syndrome) 03/2021
1	COVID-19 01/2021
1	Inflammation (Inflammations) 01/2021
1	Intraabdominal Infections 01/2018
1	Mycoses (Diseases, Fungus) 10/2016
1	Multiple Organ Failure (MODS) 10/2016
1	Invasive Fungal Infections 10/2016
1	Bacterial Pneumonia 10/2016
1	Ventilator-Associated Pneumonia 01/2012
1	Human Influenza (Influenza) 11/2010
1	Communicable Diseases (Infectious Diseases) 11/2010
1	Virus Diseases (Viral Diseases) 11/2010

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2012
2	Micafungin (FK463)FDA Link 01/2017 - 10/2016
1	Oxygen (Dioxygen)IBA 01/2023
1	AminoglycosidesIBA 03/2021
1	Complement C3b (C3bi)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2010

7	Therapeutics 01/2023 - 01/2012
1	Noninvasive Ventilation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2017
1	Mechanical Ventilators (Ventilator) 10/2016
1	Duration of Therapy 01/2012
1	Critical Care (Surgical Intensive Care) 11/2010